Main Article Content

Dr. Adel Moideen
Safiyyah Mukarram Khan
Dr. Komal Bai
Dr. Rafia Rana
Shireen Farrukh
Namratha Nalla
Nusiba Ahmed
Eaman Hamid


Type 2 diabetes, Infection, Riesgo, Studio for a short time, Diabetes mellitus, risk factors, cohort research, and prevalence


Background: Diabetes mellitus (DM) poses a significant public health concern due to its high morbidity and mortality rates, coupled with its increasing incidence and prevalence. Identifying factors associated with dysfunctional metabolic control in diabetic patients undergoing insulin treatment is crucial for effective management.

 Methods: This study aimed to identify such factors among diabetic patients admitted to the Internal Medicine Department of Hospital Nacional. A case-control design was employed, with a control group comprising diabetic patients exhibiting metabolic control at discharge and a case group comprising those with poor metabolic control. A non-probabilistic sampling method was used to select successive cases. The study included 119 patients with an average age of sixty, of whom 57% were female and 43% were male. The majority (96.5%) had type 2 diabetes and were treated with various forms of insulin, including quick, intermediate, and long-acting formulations, with NPH insulin being the most common.

Results: The type of insulin used did not significantly affect metabolic control. The control group received a lower-than-average insulin dosage. Analysis revealed that hypertension, chronic renal disease, and infections had no significant impact on glycemic control at discharge. However, a prolonged hospital stay emerged as the sole statistically significant predictor for adequate metabolic control at discharge.

 Conclusion: This study underscores the importance of identifying factors influencing metabolic control in diabetic patients undergoing insulin therapy. Prolonged hospital stays were associated with better metabolic control, highlighting the need for tailored interventions to optimize outcomes in diabetic patients, particularly during hospitalization.

Abstract 81 | PDF Downloads 38


Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019). Insulin resistance is a cardiovascular risk factor in humans. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(2), 1449-1455.
2. Collin, H.-L., Uusitupa, M., Niskanen, L., Koivisto, A.-M., Markkanen, H., & Meurman, J. H. (1998). Caries in patients with non-insulin-dependent diabetes mellitus. Oral Surgery, Medicine, Pathology, Oral Radiology, and Endodontology, 85(6), 680-685.
3. Haghighatpanah, M., Nejad, A. S. M., Haghighatpanah, M., Thunga, G., & Mallayasamy, S. (2018). Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong public health and research perspectives, 9(4), 167.
4. Hultberg, B., Agardh, C.-D., Agardh, E., & Lövestam-adrian, M. (1997). Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing plasma homocysteine levels in insulin-dependent diabetes mellitus. A five-year follow-up study. Scandinavian Journal of Clinical and Laboratory Investigation, 57(7), 595-600.
5. Karjalainen, K. M., & Knuuttila, M. L. (1996). The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin‐dependent diabetes mellitus. Journal of Clinical Periodontology, 23(12), 1060-1067.
6. Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2007). Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes: “Double diabetes” in the Diabetes Control and Complications Trial. Diabetes care, 30(3), 707-712.
7. Longo-Mbenza, B., Muaka, M., Mbenza, G., Mbungu-Fuele, S., Mabwa-Mbalanda, L., Nzuzi-Babeki, V., & Mbadi-A-Sungu, J. (2008). Risk factors of poor control of HBA1c and diabetic retinopathy: Paradox with insulin therapy and high values of HDL in African diabetic patients. International Journal of Diabetes and Metabolism, 16(2).
8. Meigs, J. B., Singer, D. E., Sullivan, L. M., Dukes, K. A., D'Agostino, R. B., Nathan, D. M., Wagner, E. H., Kaplan, S. H., & Greenfield, S. (1997). Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM Patient Outcomes Research Team. The American journal of medicine, 102(1), 38-47.
9. Mortensen, H. B., Robertson, K. J., Aanstoot, H. J., Danne, T., Holl, R., Hougaard, P., Atchison, J., Chiarelli, F., Daneman, D., & Dinesen, B. (1998). Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Diabetic Medicine, 15(9), 752-759.
10. Mulec, H., Blohmé, G., Grände, B., & Björck, S. (1998). The effect of metabolic control on the rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association, 13(3), 651-655.
11. Uusitupa, M. I., Laakso, M., Sarlund, H., Majander, H., Takala, J., & Penttilä, I. (1990). Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. The American journal of clinical nutrition, 51(5), 768-773.
12. Vaida, O., & Dahiana, J. (2016). Risk factors associated with poor metabolic control in patients with diabetes mellitus treated with insulin. Revista del Nacional (Itauguá), 8(1), 10-16.
13. Wikby, A., Hörnquist, J.-O., Stenström, U., & Andersson, P.-O. (1993). Background factors, long-term complications, quality of life and metabolic control in insulin-dependent diabetes. Quality of Life Research, 2, 281-286.
14. Zhang, L., Krzentowski, G., Albert, A., & Lefebvre, P. J. (2001). Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes care, 24(7), 1275-1279.

Most read articles by the same author(s)